ARCHIVES

NCI Offers Informations, Resources, To Industry.

This article is from The Cancer Letter archive.

Vol. 27 No. 14 | April 6, 2001

Download PDF Visit The Full Archive

Related Articles

House Committee Investigates ESA Safety, Urges Amgen, J&J, To Stop Promotions.

March 23, 2007

Clinical Trial Pathology Improvements Recommended By Group Remaining Actions After Merit Review

January 12, 1979

ASCO Annual Meeting: PARP Inhibitors Show Promise Against Breast Cancer In Small Phase II Studies

June 5, 2009

Tafinlar Subgroup Data Shows Median OS of 20 Months

October 31, 2014

EPIC, PLCO Studies Show High Fiber Diet Cuts Cancer Risk

May 2, 2003

CIS Recompetition Approved, But BSC Delays Decision On Matching Requirement

May 15, 1987